Phase II multicentre, double-blind, randomised trial of ustekinumab in adolescents with new-onset type 1 diabetes (USTEK1D): trial protocol
Guardado en:
Autores principales: | Greg W Fegan, Hayley Anne Hutchings, Colin Dayan, Stephen Hiles, Stephen Luzio, Nadim Bashir, Gail Holland, Amy Brown, Wai Yee Cheung, Kymberley Carter, Jane Bowen-Morris, Gareth Dunseath, Timothy Tree, Jennie Hsiu Mien Yang, Ashish Marwaha, Mohammad Alhadj Ali, Rachel Stenson, Susie Marques-Jones, Danijela Tatovic |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
BMJ Publishing Group
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/d5e726365cee4719beab3e1123b07807 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Ustekinumab in the therapy of chronic plaque psoriasis
por: Jenna L O’Neill, et al.
Publicado: (2009) -
Clinical utility of ustekinumab in Crohn’s disease
por: Kotze PG, et al.
Publicado: (2018) -
Potential role of ustekinumab in the treatment of chronic plaque psoriasis
por: Santo Raffaele Mercuri, et al.
Publicado: (2010) -
Profile of ustekinumab and its potential in the treatment of active psoriatic arthritis
por: Montepaone M, et al.
Publicado: (2014) -
Metabolic implications when employing heavy pre- and post-exercise rapid-acting insulin reductions to prevent hypoglycaemia in type 1 diabetes patients: a randomised clinical trial.
por: Matthew D Campbell, et al.
Publicado: (2014)